Benign Prostatic Hyperplasia, Singapore - Shim Clinic
Benign prostatic hyperplasia
Latest NewsMedical News Today: Can saw palmetto reduce enlarged prostate?
Fri, 25 May 2018 02:00:00 +0800 | Health News from Medical News Today
Saw palmetto is an herbal remedy with many potential uses in healthcare. One such use is the treatment of benign prostate hyperplasia (BPH). Although a popular remedy, research into the herb ’s efficacy is still ongoing and the results to date are inconclusive. Here, we look at the other treatments also available. (Source: Health News from Medical News Today)
Medical News Today: Can BPH cause kidney failure?
Thu, 24 May 2018 02:00:00 +0800 | Health News from Medical News Today
Benign prostatic hyperplasia (BPH) refers to enlargement of the prostate that is unrelated to cancer. Because of the positions of the prostate and kidneys, an enlarged prostate can cause kidney, or renal, failure. Knowing the symptoms can ensure quick treatment. Learn about the links between renal failure and BPH here. (Source: Health News from Medical News Today)
Medical News Today: Is green tea good for BPH?
Wed, 23 May 2018 19:00:00 +0800 | Health News from Medical News Today
There are many potential treatments for an enlarged prostate or benign prostatic hyperplasia (BPH). Many people look to green tea to manage their BPH, and the science suggests that it may offer relief for some symptoms, and provide other health benefits. Learn more about green tea for BPH, and whether it works, here. (Source: Health News from Medical News Today)
Procept BioRobotics touts early results from AquaBeam BPH waterjet ablation trial
Mon, 21 May 2018 20:55:49 +0800 | Mass Device
Procept BioRobotics today released early results from a study of its AquaBeam waterjet ablation therapy system designed for the endoscopic resection of prostate tissue exploring its use in treating benign prostatic hyperplasia, touting that it already met its primary safety and efficacy endpoints. Results were presented at the American Urological Association’s annual meeting in San Francisco by study co-principal investigator Dr. Mihir Desai of the Keck School of Medicine of USC, the Redwood Shores, Calif.-based company said. The AquaBeam system uses a robotically controlled waterjet to ablate prostate tissue without needing heat, Procept said. The 101-patient trial sought to explore its ability to treat urinary symptoms due to BPH at 16 sites across the US and Canada. Data from the...
Teleflex ’ s NeoTract wins AUA support for UroLift system as standard-of-care
Fri, 18 May 2018 22:33:06 +0800 | Mass Device
Teleflex (NYSE:TFX) subsidiary NeoTract said today that the American Urological Association now recommends the use of NeoTract’s UroLift system as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. The company’s UroLift system uses tiny devices inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside tissue from the enlarged prostate, the Pleasanton, Calif.-based company said. In a set of newly released clinical guidelines, the AUA recommends that the UroLift prostatic urethral lift procedure “should be considered for the management of men’s lower urinary tract symptoms attributed to BPH.” The guidelines were developed by a panel of experts, NeoTract said...
Mayo Clinic Q and A: New steam treatment for benign prostatic hyperplasia
Tue, 08 May 2018 07:00:00 +0800 | News from Mayo Clinic
DEAR MAYO CLINIC: I was diagnosed with benign prostatic hyperplasia four years ago. It didn?t bother me at first, so my health care provider recommended watchful waiting. But now it?s causing quite a few problems, and we?re talking about surgery. I heard there?s a new treatment for benign prostatic hyperplasia that involves steam. Does it [...] (Source: News from Mayo Clinic)
Boston Scientific Closes NxThera Acquisition
Mon, 30 Apr 2018 19:56:39 +0800 | HSMN NewsFeed
MARLBOROUGH, Mass., April 30, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The company developed the Rezūm® system, a minimally invasive thera... Devices, Urology, Mergers & Acquisitions Boston Scientific, NxThera, Rezum system, benign prostatic hyperplasia (Source: HSMN NewsFeed)
Boston Scientific closes $400m NxThera buy
Mon, 30 Apr 2018 19:50:50 +0800 | Mass Device
Boston Scientific (NYSE:BSX) said today that closed the $406 million acquisition of NxThera and its Rezūm benign prostatic hyperplasia device, which uses steam to ablate excess prostate tissue. The deal called for $306 million in up-front cash from Marlborough, Mass.-based Boston Scientific, with another $100 million in potential milestones over the next four years. Boston, which in December 2015 led a $40 million funding round for NxThera, said the existing investment means it will have to put $240 million down and another $85 million on the table in milestones. NxThera is based in Maple Grove, Minn. When Boston Scientific paid $1.6 billion to Endo (NSDQ:ENDP) for the urology portfolio Endo had acquired from American Medical Systems, it also inherited an earlier investment...
New prostate therapy recommended on NHS
Wed, 25 Apr 2018 06:39:32 +0800 | BBC News | Health | UK Edition
It's non-surgical and can treat an enlarged, non-cancerous condition called benign prostatic hyperplasia. (Source: BBC News | Health | UK Edition)
Embolx wins $2m NIH grant for pressure-directed embolization therapy
Sat, 07 Apr 2018 02:00:04 +0800 | Mass Device
Embolx said today that it landed a $2 million grant from the National Cancer Institute to fund development of its next-generation Sniper balloon occlusion microcatheter. The Sunnyvale, Calif.-based medical device company has developed a drug-delivery system that administers therapies into targeted areas of the body by controlling pressure. Embolx’s Sniper balloon is designed to treat cancerous tumors, benign prostatic hyperplasia and uterine fibroids, according to the company. Get the full story at our sister site, Drug Delivery Business News. The post Embolx wins $2m NIH grant for pressure-directed embolization therapy appeared first on MassDevice. (Source: Mass Device)
- Functional disorders: Sexual dysfunction
- Inflammatory conditions
- Degenerative disorders
- Developmental disorders of the penis
- Developmental disorders of the testis